Sources: CBC
Pfizer and its German partner BioNTech begin a clinical trial to test the safety and immune response of their Omicron-specific COVID-19 vaccine for adults under the age of 55 years. 2022-01-25
Honduras signs an agreement with Pfizer and BioNTech to purchase additional 2.7 million doses of the Pfizer-BioNTech COVID-19 vaccine in order to ensure the country will have enough supply to vaccinate all people over the age of 12 this year. 2021-08-26
Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses. 2021-01-12
Iraq signs a preliminary deal to receive 1.5 million doses of the Pfizer-BioNTech vaccine Tozinameran. Ministry of Health spokesman Seif al-Badr says troops and the elderly will be prioritized for vaccinations. 2020-12-22
President-elect Joe Biden and incoming First Lady Dr. Jill Biden receive their first shot of the Pfizer BioNTech vaccine on live television to reassure Americans of the safety of vaccines. Meanwhile, Vice President-elect Kamala Harris and incoming Second Gentleman Doug Emhoff announce that they will receive their vaccines next week. 2020-12-21
Singapore receives the Pfizer-BioNTech vaccine, becoming the first country in Asia to do so. 2020-12-21
The European Medicines Agency conditionally approves the vaccine made by Pfizer and BioNTech for use in European Union countries. 2020-12-21
Israeli Prime Minister Benjamin Netanyahu became the first person in Israel to receive the vaccine made by Pfizer and BioNTech and getting the shot on live television. 2020-12-19
Kuwait's Ministry of Health approves an Emergency Use Authorization of the Pfizer-BioNtech vaccine. 2020-12-13
Prime Minister Justin Trudeau says that the country will receive 240,000 doses of Pfizer and BioNTech’s vaccine candidate by the end of the year. 2020-12-7